Michael Murdock joined RadNet in November of 2006 upon the acquisition of Radiologix by RadNet. Mike was Senior Vice President and Chief Financial Officer of Radiologix since January 2005.
Mike has spent the majority of his career in senior financial positions with health care companies, including positions with American Medical International and its successor American Medical Holdings, Inc., a $2.4 billion in revenue publicly traded owner and operator of acute care facilities that was acquired by National Medical Enterprises, now Tenet Healthcare.
Mike also served as Chief Financial Officer of Physician Reliance Network, Inc., a $398 million in revenue publicly traded physician practice management company, specializing in oncology. In 1999, PRN merged with American Oncology, Inc. to become U.S. Oncology, Inc., the nation’s largest healthcare network dedicated to cancer treatment and research. From 1999 through 2004, Mike served as CFO of Dental One, a venture capital-backed owner and operator of 48 dental practices in Texas, Arizona, Colorado, and Utah. Mike began his career in 1978 as an auditor with Arthur Andersen after receiving a B.S. degree from California State University, Northridge.
What is Michael N. Murdock's net worth?
The estimated net worth of Michael N. Murdock is at least $3.95 million as of August 21st, 2024. Mr. Murdock owns 48,144 shares of RadNet stock worth more than $3,949,734 as of November 22nd. This net worth evaluation does not reflect any other investments that Mr. Murdock may own. Learn More about Michael N. Murdock's net worth.
How do I contact Michael N. Murdock?
Has Michael N. Murdock been buying or selling shares of RadNet?
Michael N. Murdock has not been actively trading shares of RadNet during the last quarter. Most recently, Michael N. Murdock sold 15,000 shares of the business's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $62.78, for a transaction totalling $941,700.00. Following the completion of the sale, the executive vice president now directly owns 48,144 shares of the company's stock, valued at $3,022,480.32. Learn More on Michael N. Murdock's trading history.
Who are RadNet's active insiders?
Are insiders buying or selling shares of RadNet?
In the last year, insiders at the medical research company sold shares 14 times. They sold a total of 166,402 shares worth more than $10,599,203.03. The most recent insider tranaction occured on November, 19th when insider Ranjan Jayanathan sold 38,557 shares worth more than $3,084,560.00. Insiders at RadNet own 5.1% of the company.
Learn More about insider trades at RadNet. Information on this page was last updated on 11/19/2024.
